| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0069 | 1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0077 | 1 |